142 related articles for article (PubMed ID: 3130490)
1. Effect of fibronectin-rich human cryoprecipitate on fluid volume requirements in sheep during postoperative sepsis.
Holman JM; Saba TM; Lewis E
J Trauma; 1988 May; 28(5):571-81. PubMed ID: 3130490
[TBL] [Abstract][Full Text] [Related]
2. Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.
Saba TM; Niehaus GD; Scovill WA; Blumenstock FA; Newell JC; Holman J; Powers SR
Ann Surg; 1983 Nov; 198(5):654-62. PubMed ID: 6416192
[TBL] [Abstract][Full Text] [Related]
3. Lung fluid and protein flux during postoperative sepsis.
Holman JM; Saba TM; Niehaus GD; Lewis E
Circ Shock; 1985; 17(2):121-36. PubMed ID: 4053299
[TBL] [Abstract][Full Text] [Related]
4. Lung matrix incorporation of plasma fibronectin reduces vascular permeability in postsurgical bacteremia.
Resnikoff M; Brien T; Vincent PA; Rotundo RF; Lewis E; McKeown-Longo PJ; Saba TM
Am J Physiol; 1999 Oct; 277(4):L749-59. PubMed ID: 10516216
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin in severe sepsis.
Stevens LE; Clemmer TP; Laub RM; Miya F; Robbins L
Surg Gynecol Obstet; 1986 Mar; 162(3):222-8. PubMed ID: 3082023
[TBL] [Abstract][Full Text] [Related]
6. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations.
Saba TM; Blumenstock FA; Shah DM; Landaburu RH; Hrinda ME; Deno DC; Holman JM; Cho E; Dayton C; Cardarelli PM
Am J Med; 1986 Feb; 80(2):229-40. PubMed ID: 3946437
[TBL] [Abstract][Full Text] [Related]
7. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a difference?
Su F; Wang Z; Cai Y; Rogiers P; Vincent JL
Shock; 2007 May; 27(5):520-6. PubMed ID: 17438457
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of circulating fibronectin into various tissues during sepsis: colocalization with endogenous tissue fibronectin.
Jin HM; Vincent PA; Charash WE; Saba TM; McKeown-Longo P; Blumenstock FA; Lewis E
Exp Mol Pathol; 1991 Dec; 55(3):203-16. PubMed ID: 1748211
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
[TBL] [Abstract][Full Text] [Related]
10. Plasma fibronectin levels in clinical disease states and after cryoprecipitate infusion.
Ragni MV; Lewis JH; Spero JA; Bontempo FA
Thromb Haemost; 1984 Dec; 52(3):321-4. PubMed ID: 6442471
[TBL] [Abstract][Full Text] [Related]
11. Plasma fibronectin therapy and lung protein clearance with bacteremia after surgery.
Cohler LF; Saba TM; Lewis E; Vincent PA; Charash WE
J Appl Physiol (1985); 1987 Aug; 63(2):623-33. PubMed ID: 3654422
[TBL] [Abstract][Full Text] [Related]
12. Reversal of fibronectin and opsonic deficiency in patients. A controlled study.
Saba TM; Blumenstock FA; Shah DM; Kaplan JE; Cho E; Scovill W; Stratton H; Newell J; Gottlieb M; Sedransk N
Ann Surg; 1984 Jan; 199(1):87-96. PubMed ID: 6362585
[TBL] [Abstract][Full Text] [Related]
13. Cryoprecipitate infusion fails to improve organ function in septic shock.
Hesselvik F; Brodin B; Carlsson C; Cedergren B; Jorfeldt L; Liedén G
Crit Care Med; 1987 May; 15(5):475-83. PubMed ID: 3552444
[TBL] [Abstract][Full Text] [Related]
14. Influence of opsonic fibronectin deficiency on lung fluid balance during bacterial sepsis.
Niehaus GD; Schumacker PT; Saba TM
J Appl Physiol Respir Environ Exerc Physiol; 1980 Oct; 49(4):693-9. PubMed ID: 7440283
[TBL] [Abstract][Full Text] [Related]
15. Burn resuscitation: crystalloid versus colloid versus hypertonic saline hyperoncotic colloid in sheep.
Guha SC; Kinsky MP; Button B; Herndon DN; Traber LD; Traber DL; Kramer GC
Crit Care Med; 1996 Nov; 24(11):1849-57. PubMed ID: 8917036
[TBL] [Abstract][Full Text] [Related]
16. Plasma fibronectin levels in sepsis: influencing factors.
Hesselvik JF
Crit Care Med; 1987 Dec; 15(12):1092-7. PubMed ID: 3677761
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of circulating bacterial or nonbacterial particulates on plasma fibronectin: relationship to lung deposition of blood-borne foreign particles.
Kiener JL; Cho E; Saba TM
Circ Shock; 1986; 19(4):357-70. PubMed ID: 3742738
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of factor VIII-rich cryoprecipitate and the plasma fibronectin-rich, heparin-precipitable fraction prepared from single-donor plasma units.
Menitove JE; Amrani DL; Meh D; Frenzke M; Mosesson MW
Transfusion; 1987; 27(6):491-5. PubMed ID: 3500532
[TBL] [Abstract][Full Text] [Related]
19. Cryoprecipitate therapy in amniotic fluid embolization.
Rodgers GP; Heymach GJ
Am J Med; 1984 May; 76(5):916-20. PubMed ID: 6426302
[TBL] [Abstract][Full Text] [Related]
20. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
